Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2001-8-6
pubmed:abstractText
Vascular endothelial growth factor (VEGF) has been identified as an important factor for tumour angiogenesis, which is essential for the growth, invasion and metastasis of solid tumours. Significantly increased VEGF level from the primary tumour to the metastatic lesion of ovarian cancers was found in 8 of 30 cases. The 24-month survival rate of the patients with significantly increased VEGF level was extremely poor (0/8 = 0%) in comparison with that of patients with no change in the level (15/22 = 68%) from the primary tumour to the metastatic lesion. This indicates that VEGF may contribute to the advancement of metastatic lesions, and that VEGF level in metastatic lesions may be a prognostic indicator.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/11487257-10360662, http://linkedlifedata.com/resource/pubmed/commentcorrection/11487257-10381125, http://linkedlifedata.com/resource/pubmed/commentcorrection/11487257-10454244, http://linkedlifedata.com/resource/pubmed/commentcorrection/11487257-10479500, http://linkedlifedata.com/resource/pubmed/commentcorrection/11487257-10537299, http://linkedlifedata.com/resource/pubmed/commentcorrection/11487257-2479986, http://linkedlifedata.com/resource/pubmed/commentcorrection/11487257-2479987, http://linkedlifedata.com/resource/pubmed/commentcorrection/11487257-2581424, http://linkedlifedata.com/resource/pubmed/commentcorrection/11487257-6823562, http://linkedlifedata.com/resource/pubmed/commentcorrection/11487257-7535799, http://linkedlifedata.com/resource/pubmed/commentcorrection/11487257-7707437, http://linkedlifedata.com/resource/pubmed/commentcorrection/11487257-7779407, http://linkedlifedata.com/resource/pubmed/commentcorrection/11487257-7937592, http://linkedlifedata.com/resource/pubmed/commentcorrection/11487257-8276298, http://linkedlifedata.com/resource/pubmed/commentcorrection/11487257-8380810, http://linkedlifedata.com/resource/pubmed/commentcorrection/11487257-8466753, http://linkedlifedata.com/resource/pubmed/commentcorrection/11487257-8667614, http://linkedlifedata.com/resource/pubmed/commentcorrection/11487257-8752175, http://linkedlifedata.com/resource/pubmed/commentcorrection/11487257-8962129, http://linkedlifedata.com/resource/pubmed/commentcorrection/11487257-9210714, http://linkedlifedata.com/resource/pubmed/commentcorrection/11487257-945947, http://linkedlifedata.com/resource/pubmed/commentcorrection/11487257-9699643, http://linkedlifedata.com/resource/pubmed/commentcorrection/11487257-9874459
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
0007-0920
pubmed:author
pubmed:copyrightInfo
Copyright 2001 Cancer Research Campaign.
pubmed:issnType
Print
pubmed:day
3
pubmed:volume
85
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
313-6
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
2001
pubmed:articleTitle
Clinical implications of expression of vascular endothelial growth factor in metastatic lesions of ovarian cancers.
pubmed:affiliation
Department of Obstetrics and Gynecology, Gifu University School of Medicine, 40 Tsukasa-machi, Gifu City, 500-8705, Japan.
pubmed:publicationType
Journal Article